澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ACTINOGEN MEDICAL LTD

0.044

+0.0012.33%

成交量：79.69萬

成交額：3.50萬

市值：1.64億

市盈率：-7.61

高：0.045

開：0.044

低：0.043

收：0.043

52周最高：0.072

52周最低：0.026

股本：37.17億

流通股本：26.08億

量比：0.78

換手率：0.03%

股息：- -

股息率：- -

每股收益(TTM):-0.006

每股收益(LYR):-0.005

淨資產收益率：-110.77%

總資產收益率：-63.83%

市淨率：19.54

市盈率(LYR):-8.90

資料載入中...

總覽公司新聞資訊公告

Actinogen獲EMA積極科學建議，與其先前針對阿爾茨海默病項目獲得的FDA指導方向一致

Actinogen Medical本季度計劃與EMA會面探討簡化Xanamem歐盟審批路徑

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/ACW.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ACW.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACW.AU\",,,,,undefined,":{"symbol":"ACW.AU","market":"AU","secType":"STK","nameCN":"ACTINOGEN MEDICAL LTD","latestPrice":0.044,"timestamp":1787638320000,"preClose":0.043,"halted":0,"volume":796941,"delay":0,"changeRate":0.023255813953488396,"nameEN":"ACTINOGEN MEDICAL LTD","floatShares":2607880613,"shares":3717091613,"eps":-0.005783,"marketStatus":"未開盤","change":0.001,"latestTime":"08-25 16:12:00 AEST","open":0.044,"high":0.045,"low":0.043,"amount":34952,"amplitude":0.046512,"askPrice":0.045,"askSize":495350,"bidPrice":0.044,"bidSize":284604,"shortable":3,"etf":0,"ttmEps":-0.005783,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.043,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.780735,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ACW.AU","preClose":0.043,"auctionPrice":0.044,"auctionVolume":3792,"auction":3,"marketStatus":"盘后竞价","timestamp":1787637622902}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACW.AU\",,,,,undefined,":{"symbol":"ACW.AU","floatShares":2607880613,"roa":"-63.83%","roe":"-110.77%","lyrEps":-0.004944,"volumeRatio":0.780735,"shares":3717091613,"dividePrice":0,"high":0.045,"amplitude":0.046512,"preClose":0.043,"low":0.043,"week52Low":0.026,"pbRate":"19.54","psRate":"22.21","week52High":0.072,"institutionHeld":0,"latestPrice":0.044,"committee":-0.270203,"eps":-0.005783,"divideRate":0,"volume":796941,"delay":0,"ttmEps":-0.005783,"open":0.044,"prevYearClose":0.061,"prevWeekClose":0.046,"prevMonthClose":0.041,"prevQuarterClose":0.031,"fiveDayClose":0.044,"twentyDayClose":0.041,"sixtyDayClose":0.04,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACW.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-10-19","symbol":"ACW.AU","defaultRemindTime":1603062000000,"type":"split","dateTimestamp":1603026000000,"forFactor":98,"toFactor":100,"ratio":0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACW.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACW.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1128108625","title":"Actinogen獲EMA積極科學建議，與其先前針對阿爾茨海默病項目獲得的FDA指導方向一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1128108625","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128108625?lang=zh_tw&edition=fundamental","pubTime":"2026-05-28 20:03","pubTimestamp":1779969792,"startTime":"0","endTime":"0","summary":"Actinogen Medical Ltd. 在推进其阿尔茨海默病治疗项目方面取得了重要进展。该公司宣布，已获得欧洲药品管理局（EMA）的积极科学建议，该建议与此前美国食品药品监督管理局（FDA）提供的指导方向保持一致。\n这一积极反馈为该公司关键临床项目的下一步发展路径提供了明确的监管支持。获得两大主要监管机构在科学和监管策略上的一致性认可，显著增强了该药物开发计划的可预测性与成功前景。\n对于专注于神经退行性疾病领域的生物技术公司而言，此类监管协同至关重要。它不仅能优化全球开发策略，还可能加速未来在多个主要市场的审评进程。此次进展预计将进一步提升投资者对该项目及其长期潜力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","ACW.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160930623","title":"Actinogen Medical本季度計劃與EMA會面 探討簡化Xanamem歐盟審批路徑","url":"https://stock-news.laohu8.com/highlight/detail?id=1160930623","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160930623?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 20:35","pubTimestamp":1775046911,"startTime":"0","endTime":"0","summary":"生物制药公司Actinogen Medical Ltd宣布，将在本季度与欧洲药品管理局（EMA）举行会议。此次会晤的核心议题是探讨如何优化和简化其主打候选药物Xanamem在欧盟地区的审批流程，旨在加速该药物的上市进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACW.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}